Jerry S. Lanchbury - 23 Sep 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Issuer symbol
MYGN
Transactions as of
23 Sep 2021
Transactions value $
-$452,700
Form type
4
Date filed
27 Sep 2021, 19:40
Previous filing
23 Sep 2021
Next filing
12 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Sale -$7.01K -200 -0.07% $35.06 289K 23 Sep 2021 Direct F1
transaction MYGN Common Stock Tax liability -$325K -9.75K -3.38% $33.31 279K 25 Sep 2021 Direct F2
transaction MYGN Common Stock Tax liability -$121K -3.63K -1.3% $33.31 275K 26 Sep 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.